Brooks Automation Announces Participation in the 12th Annual Virtual CEO Investor Summit 2020

Rhea-AI Summary

Brooks Automation (Nasdaq: BRKS) announced its upcoming participation in the 12th Annual Virtual CEO Investor Summit on December 16, 2020. This event, which is invitation-only for accredited investors and research analysts, will feature a round-robin format with up to six 40-minute meetings dedicated to discussing the company's business and opportunities. The company specializes in life science sample management and semiconductor manufacturing solutions. Brooks is headquartered in Chelmsford, MA, and serves clients globally.

Positive

• Participation in a high-profile investor summit to enhance visibility and engagement with investors.
• Brooks Automation's diverse operations in life sciences and semiconductor sectors indicate broad market presence.

Negative

• None.

CHELMSFORD, Mass., Dec. 7, 2020 /PRNewswire/ -- Brooks Automation, Inc. (Nasdaq:BRKS) announced today that the Company's management will participate in the 12^th Annual Virtual CEO Investor Summit 2020 being held on December 16, 2020.

About the 12^th Annual Virtual CEO Summit 2020
The CEO Summit is hosted by executive management from participating companies and will feature a virtual "round-robin" format consisting of small group meetings, each 40 minutes in duration.  Each company will be available for up to six meeting slots during the conference.  The Virtual CEO Summit is by invitation only and is open to accredited investors and publishing research analysts.   Please contact the event's co-chairs with any questions related to the event:  Laura J. Guerrant-Oiye, Guerrant Associates – email: laura@ga-ir.com or Claire E. McAdams, Headgate Partners LLC – email:  Claire@headgatepartners.com.

About Brooks Automation
Brooks (Nasdaq: BRKS) is a leading provider of life science sample-based solutions and semiconductor manufacturing solutions worldwide.  The Company's Life Sciences business provides a full suite of reliable cold-chain sample management solutions and genomic services across areas such as drug development, clinical research and advanced cell therapies for the industry's top pharmaceutical, biotech, academic and healthcare institutions globally.  Brooks Life Sciences' GENEWIZ division is a leading provider of gene sequencing and gene synthesis services.  With over 40 years as a partner to the semiconductor manufacturing industry, Brooks is a provider of industry-leading precision vacuum robotics, integrated automation systems and contamination control solutions to the world's leading semiconductor chip makers and equipment manufacturers.  Brooks is headquartered in Chelmsford, MA, with operations in North America, Europe and Asia.  For more information, visit www.brooks.com.

INVESTOR CONTACTS: 
Sherry Dinsmore
Brooks Automation
978.262.4301
sherry.dinsmore@brooks.com

John Mills
Managing Partner
ICR, LLC
646.277.1254
john.mills@icrinc.com

 

View original content to download multimedia:http://www.prnewswire.com/news-releases/brooks-automation-announces-participation-in-the-12th-annual-virtual-ceo-investor-summit-2020-301187657.html

SOURCE Brooks Automation

FAQ

What is the date of the 12th Annual Virtual CEO Investor Summit for Brooks Automation?

The summit is scheduled for December 16, 2020.

What does Brooks Automation specialize in?

Brooks Automation specializes in life science sample management and semiconductor manufacturing solutions.

What type of investors can attend the Virtual CEO Investor Summit?

The summit is open to accredited investors and publishing research analysts.

Where is Brooks Automation headquartered?

Brooks Automation is headquartered in Chelmsford, Massachusetts.

What format will the CEO Investor Summit follow?

The summit will feature a round-robin format with small group meetings lasting 40 minutes each.